A rare neurological disease is Sage’s last, best hope after failures in depression

In 2010, neuroscientist and former Eli Lilly research leader Steve Paul started a company that he hoped would spark a revolution in drug discovery, built around a class of compounds dubbed neurosteroids that could help ...